CRLC Val d'Aurelle

Montpellier 34298

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Kidney Neoplasms, Metastatic Pancreatic Cancer, Pancreatic Cancer

Studies at this site

• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies — Completed
• Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer — Stopped early
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer — Completed